Fused Heteroaryl Compounds for Selective Sodium Channel Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neurological and cardiac conditions associated with abnormal late or persistent sodium current (INaL) are inadequate, as they often fail to selectively modulate sodium channel activity effectively.
Innovation Solution
Development of fused heteroaryl compounds and compositions that can selectively modulate sodium channel activity, specifically targeting abnormal INaL, to treat conditions related to aberrant sodium ion channel function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments are used for neurological and cardiac conditions, then they are administered to patients, but they fail to selectively modulate sodium channel activity effectively
Solution Approach 1:
The patent applies local quality by designing compounds with specific structural features (fused heteroaryl rings with particular substituent patterns) that confer selective affinity for abnormal sodium channel states. The molecular structure incorporates specific functional groups and ring systems that interact preferentially with pathological sodium channels while sparing normal channels, achieving selective modulation through localized molecular properties.
Solution Approach 2:
The patent employs parameter changes by systematically varying molecular parameters such as ring size, substituent types, and molecular configuration to optimize selectivity for abnormal sodium channels. By adjusting these chemical parameters, the compounds achieve differential binding affinity for pathological versus normal sodium channel states, resolving the contradiction between selectivity and effectiveness.
2Reliability
If fused heteroaryl compounds are developed to selectively modulate sodium channel activity, then they can target abnormal INaL, but the complexity of compound structure increases
Solution Approach 1:
The patent applies segmentation by dividing the molecular structure into distinct functional modules: a core fused heteroaryl ring system, specific substituent groups at defined positions, and linker moieties. This modular segmentation allows systematic optimization of selectivity while maintaining manageable structural complexity through organized functional domains.
Solution Approach 2:
The patent employs composite materials principles by combining different heteroaryl ring systems with specific substituent patterns to create composite molecular structures. These composite compounds integrate multiple functional elements that work synergistically to achieve selective binding to abnormal sodium channels, balancing enhanced selectivity with controlled molecular complexity.
Data Source
AI summary
The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.


